Q32 Bio Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $169.7M | $108.4M |
| FY2022 | — | $-130.7M | $34.0M |
| FY2023 | — | $-182.9M | $25.6M |
| FY2024 | — | $5.7M | $78.0M |
| FY2025 | — | $42.0M | $48.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $169.7M | $108.4M |
| FY2022 | — | $-130.7M | $34.0M |
| FY2023 | — | $-182.9M | $25.6M |
| FY2024 | — | $5.7M | $78.0M |
| FY2025 | — | $42.0M | $48.3M |